Targeting Transcription Factors with AI, featuring Will Fondrie from Talus Bio

A new episode of Data in Biotech is live!

In this episode of Data in Biotech, Ross Katz sits down with William Fondrie, Head of Data Science and Engineering at Talus Bio, to explore how machine learning, mass spectrometry, and innovative computational models are transforming drug discovery. Learn how Talus Bio is targeting transcription factors—once considered out of reach—with scalable, high-impact data science.

Listen now wherever you find your podcasts.

Apple Podcasts
Spotify
YouTube